PODCAST · science
Cell + Gene: Unfiltered
by Michael Adeniya
A podcast for the cell and gene therapy community.Advanced therapies are revolutionizing the way disease is treated, but existing therapies have their limits.Anthony Davies and Michael Adeniya expose the truth through candid conversations with the greatest minds in cell and gene therapy.
-
1
Ep1: what gives investors the ‘ick’?
Jason Mellad, CEO at Start Codon and Mark Bonyhadi at Qiming Ventures kick off the podcast in episode one of Cell and Gene: Unfiltered. We talk about what gives them ‘the ick’ and some of the most common cardinal mistakes made during investor pitches. Our guests show no signs of dancing around the issues and discussing what makes investors perk up and pay attention. Does novelty immediately make a product investment worthy? The answer is a firm ‘no’ from Jason… We also reflect on the collapse of SVB, the European rescue by HSBC, and the potential impact for the CGT field. Don’t miss Mark and Anthony’s Christmas wish list of tech too! Tune in for no-nonsense, actionable, specific advice and insights from two uniquely experienced execs. Send us your feedback at [email protected]
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
A podcast for the cell and gene therapy community.Advanced therapies are revolutionizing the way disease is treated, but existing therapies have their limits.Anthony Davies and Michael Adeniya expose the truth through candid conversations with the greatest minds in cell and gene therapy.
HOSTED BY
Michael Adeniya
Loading similar podcasts...